| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.009 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.02 |